<SEC-DOCUMENT>0001415889-25-000009-index.html : 20250102
<SEC-HEADER>0001415889-25-000009.hdr.sgml : 20250102
<ACCEPTANCE-DATETIME>20250102092146
ACCESSION NUMBER:		0001415889-25-000009
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250101
FILED AS OF DATE:		20250102
DATE AS OF CHANGE:		20250102

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Morris Charles Q
		CENTRAL INDEX KEY:			0001489966
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40241
		FILM NUMBER:		25500450

	MAIL ADDRESS:	
		STREET 1:		C/O LAVA THERAPEUTICS BV
		STREET 2:		YALEAAN 62
		CITY:			3584 CM ULTRECHT
		STATE:			P7
		ZIP:			3585 CM

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LAVA Therapeutics NV
		CENTRAL INDEX KEY:			0001840748
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		YALELAAN 62
		CITY:			UTRECHT
		STATE:			P7
		ZIP:			3584 CM
		BUSINESS PHONE:		31 6 3000 3035

	MAIL ADDRESS:	
		STREET 1:		YALELAAN 62
		CITY:			UTRECHT
		STATE:			P7
		ZIP:			3584 CM

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LAVA Therapeutics BV
		DATE OF NAME CHANGE:	20210115
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3-01022025_020143.xml
<TEXT>
Document 1 - file: form3-01022025_020143.html

Document 1 - RAW XML: form3-01022025_020143.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ex24-01022025_020144.htm
<TEXT>
Document 2 - file: ex24-01022025_020144.htm

</DOCUMENT>
</SEC-DOCUMENT>